Accession Number:



Population Health Trial for Smokeless Tobacco Cessation with Military Personnel

Descriptive Note:

Annual rept. 1 May 2004-30 Apr 2005

Corporate Author:


Personal Author(s):

Report Date:


Pagination or Media Count:



While smoking cessation has received considerable attention within the military, the use of smokeless tobacco chewing tobacco and snuff has not been a focus of medical services or research. Epidemiological data suggest that while smoking has continued to decline both in the general population and within the military, the use of smokeless tobacco products has increased. The primary objective of this research is to develop and evaluate an intervention for smokeless tobacco cessation consisting of proactive recruitment, mailings of targeted written and video materials to participants, and phone call support. The primary hypothesis to be tested is that participants randomized to receive the intervention will quit their tobacco use at a significantly higher rate than participants receiving usual care. Active duty U.S. Armed Forces personnel stationed at military locations that are identified as current smokeless tobacco users when completing their annual preventive oral health assessment will be recruited to participate in a randomized two-group design that compares a brief contact intervention with the usual preventive health care. Follow up assessments by mail at 3 months and 6 months after randomization will assess the impact of the program. By the end of the studys 3rd year, orientation and training visits had been conducted at dental clinics in 14 additional military installations 6 Air Force sites 5 Army sites Camp Pendleton, CA, for Marine enrollment and 2 Navy clinics in San Diego. A total of 667 participants have now been enrolled in the study. Mailings of follow-up assessments at 3 and 6 months post-enrollment have continued, with 313 3-month surveys and 233 6-month surveys completed to date.

Subject Categories:

  • Psychology
  • Medicine and Medical Research
  • Toxicology

Distribution Statement: